Acute Kidney Injury in Neonatal ICU in Assuit University
NCT ID: NCT07083284
Last Updated: 2025-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2025-08-01
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The precocious diagnosis of AKI based on urinary output and serum creatinine (sCr) levels represents one of the hardest challenges in clinical practice. Several biomarkers and clinical scores were assessed to predict neonatal AKI, to identify the stage of injury and not the damage, to anticipate late rises in sCr values and to reveal an already compromised renal function (7)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates
NCT02443389
Acute Kidney Injury in Neonates at NICU in Assiut University Children Hospital Descriptive Study
NCT03528837
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115
Validation of STARZ Score for Early Neonatal AKI
NCT07202858
Acute Kidney Injury in Premature Infants
NCT00573079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
patients with Age from 0 to 28 days presented with acute kidney injury on based of raised renal chemistry, An increase in serum creatinine (e.g., \>0.3 mg/dL or \>50% from baseline) , Oliguria (urine output less than 1 mL/kg/h for more than 6 hours).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Other biomarkers of kidney injury (e.g., elevated urinary biomarkers such as NGAL, KIM-1) ( if available)
* Parental consent: Neonates whose parents or legal guardians provide informed consent for participation in the study
Exclusion Criteria
* Cases with gross congenital anomalies of the kidney and urinary tract.
* Neonates with a maternal history of kidney failure.
1 Day
30 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omnia Zakaria Mostafa
residant doctor at Assiut university hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AKI neonatal ICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.